Rise and shine, oh ye weary, sleep-deprived parents. Your lives just got a little tougher.
Sardonic "thanks" go out this morning to Johnson & Johnson
What's it mean for parents?
From now on, we'll have to suffer alongside our cold-ridden children -- sadly, not in silence.
What's it mean for investors?
Obviously, it means a small dose of lost revenue and earnings at J&J, Novartis, and Wyeth, and additional lost revenue at the pharmacies that hawk their elixirs -- the likes of CVS
Maybe it's the sleep-deprived, grouchy, and starting-to-feel-a-sniffle-coming-on parent of a sick child in me talking, but I say: Serves 'em right. Misery loves company.
More from The Motley Fool
Better Buy: Johnson & Johnson vs. Merck
J&J stock is up in 2017, while Merck is down. But could the roles be reversed in 2018 and beyond?
3 Dividend Stocks With Better Yields Than Johnson & Johnson
These stocks would serve your income portfolio better than Johnson & Johnson today.
Will Johnson & Johnson Raise Its Dividend in 2018?
Find out what the healthcare giant is likely to do with its free cash in the coming year.